Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;17(4):493-507.
doi: 10.1007/s40268-017-0207-7.

Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research

Affiliations
Review

Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research

Jaden Brandt et al. Drugs R D. 2017 Dec.

Abstract

Various adverse events resulting from, or associated with, benzodiazepine and/or Z-drug use have been extensively reported on and discussed in great detail within the biomedical literature. It is widely accepted that motor vehicle accidents and falls leading to fractures in older adults are major adverse events that have been shown to occur more frequently in users of sedative-hypnotic medication, especially of the benzodiazepine and related Z-drug variety. However, the last few years have seen increasing reports in the literature raising the issue of benzodiazepine and Z-drug exposure in the development of other serious medical issues including dementia, infections, respiratory disease exacerbation, pancreatitis, and cancer. This article provides an overview and interpretation on the current state of evidence regarding each of these associations and proposes what gaps in the evidence for drug-exposure-harm associations need to be addressed in the future for the purpose of evaluating causality of harm as it relates to these drugs.

PubMed Disclaimer

Conflict of interest statement

Funding

No sources of funding were used to assist in preparing this manuscript.

Conflict of interest

JB and CL have no conflicts of interest to disclose that are relevant to the contents of this manuscript.

References

    1. Trevor AJ. Chapter 22: sedative–hypnotic drugs. In: Katzung BG, Trevor AJ, editors. Basic and clinical pharmacology, 13e. New York: McGraw-Hill Medical; 2015. http://mhmedical.com/content.aspx?aid=1104844214.
    1. World Health Organization. WHO | The top 10 causes of death. WHO. 2014. http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed 26 Jan 2017.
    1. Rudisill TM, Zhao S, Abate MA, Coben JH, Zhu M. Trends in drug use among drivers killed in US traffic crashes, 1999–2010. Accid Anal Prev. 2014;70:178–187. doi: 10.1016/j.aap.2014.04.003. - DOI - PMC - PubMed
    1. Facts about drug-impaired driving. Canadian Centre on Substance Abuse, Ottawa, CAN. 2016.
    1. Verster JC, Roth T. Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP) Int J Gen Med. 2011;4:359–371. doi: 10.2147/IJGM.S19639. - DOI - PMC - PubMed

MeSH terms